← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIVIRALS FOR SYSTEMIC USE › DIRECT ACTING ANTIVIRALS › Other antivirals
inosine pranobex
J05AX05
Forms & Strengths
- Tablets: 500mg
- Syrup: 125mg/5mL
Adult Dosing
- 1g every 4 hours orally for herpes simplex infections
- 1.5g to 3g daily in divided doses for immunomodulation
Pediatric Dosing
- For children over 6 years: 500mg to 1g every 4 hours orally
- For children under 6 years: 125mg to 250mg (5-10mL syrup) every 4 hours orally
Indications
- Treatment of herpes simplex virus infections
- Subacute sclerosing panencephalitis
- Immunomodulation in various viral and neoplastic diseases
Mechanism of Action
- Increases natural killer cell activity
- Stimulates production of interferon and other cytokines
- Has immunomodulatory and antiviral effects
Contraindications
- Hypersensitivity to inosine pranobex or its components
- Pregnancy and lactation (due to lack of safety data)
Adverse Reactions
- Gastrointestinal disturbances (nausea, vomiting, diarrhea)
- Headache and dizziness
- Allergic reactions (rash, itching, urticaria)
Drug Interactions
- May enhance effects of antiviral and immunomodulating agents
- Potential interaction with live vaccines (avoid use)
Curated Content: Needs Vetting Before Put to Clinical Use